Vancomycin Hypersensitivity: Case Reports of Successful Vancomycin Desensitization
Abstract
Background: Vancomycin infusion reaction (VIR, previously known as “red man syndrome”) and anaphylaxis are two vancomycin hypersensitivity reactions with identical and clinically indistinguishable clinical presentations.
Method: This was a retrospective study where vancomycin hypersensitivity cases who underwent vancomycin desensitization in the past two years were recruited.
Results: Two vancomycin hypersensitivity cases were labeled as allergic to vancomycin in their previous hospitalizations before being admitted to our hospitals. The first case developed facial and lips swelling, while the second case developed transient hypotension; both occurred after the first dose of intravenous vancomycin, and hence were labelled as allergies without continuation of vancomycin in the previous hospitalizations. During current hospital admissions, both patients required vancomycin to treat infections. After weighing the risks and benefits, rapid vancomycin desensitization was conducted in both patients because of budget constraints in the public hospitals for alternative antibiotics. The desensitization was successfully conducted with no recurrence of previous reactions, and both cases completed intravenous vancomycin treatment for their infections.
Conclusion: Clinical presentations in VIR and anaphylaxis might be identical and indistinguishable, especially the reactions that have happened in the past and confirmatory allergy test is not available. Our study reported that vancomycin desensitization could be conducted in cases where VIR or anaphylaxis are uncertain, with the past reactions not life-threatening, and if no other alternative antibiotic can be used to treat infections.
Downloads
References
Chopra, N., Oppenheimer, J., Derimanov, G. S., & Fine, P. L. (2000). Vancomycin anaphylaxis and successful desensitization in a patient with end stage renal disease on hemodialysis by maintaining steady antibiotic levels. Annals of Allergy, Asthma and Immunology, 84(6), 633–635. https://doi.org/10.1016/S1081-1206(10)62416-7
Eyler, R. F., & Shvets, K. (2019). Clinical pharmacology of antibiotics. Clinical Journal of the American Society of Nephrology, 14(7), 1080–1090. https://doi.org/10.2215/CJN.08140718
Kitazawa, T., Ota, Y., Kada, N., Morisawa, Y., Yoshida, A., Koike, K., & Kimura, S. (2006). Successful vancomycin desensitization with a combination of rapid and slow infusion methods. Internal Medicine, 45(5), 317–321. https://doi.org/10.2169/internalmedicine.45.1388
Kupstaitė, R., Baranauskaitė, A., Pileckytė, M., Sveikata, A., Kaduševičius, E., & Muckienė, G. (2010). Severe vancomycin-induced anaphylactic reaction. Medicina (Kaunas), 46(1), 30–33.https://doi.org/10.3390/medicina46010005
Lerner, A., & Dwyer, J. M. (1984). Desensitization to Vancomycin. Annals of Internal Medicine, 100(1), 157.
Levine, D. P. (2006). Vancomycin : A History. Clinical Infectious Diseases, 42(Suppl 1), 5–12.
Levine, D. P. (2008). Vancomycin: Understanding its past and preserving its future. Southern Medical Journal, 101(3), 284–291. https://doi.org/10.1097/SMJ.0b013e3181647037
Lin, R. Y. (1990). Desensitization in the management of vancomycin hypersensitivity. Archives of Internal Medicine, 150(10), 2197–2198. https://doi.org/10.1001/archinte.150.10.2197
Liu, C., Bayer, A., Cosgrove, S. E., Daum, R. S., Fridkin, S. K., Gorwitz, R. J., Kaplan, S. L., Karchmer, A. W., Levine, D. P., Murray, B. E., Rybak, M. J., Talan, D. A., & Chambers, H. F. (2011). Clinical practice guidelines by the Infectious Diseases Society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children. Clinical Infectious Diseases, 52(3), e18–e55. https://doi.org/10.1093/cid/ciq146
Paiva, J. A., & Eggimann, P. (2017). Treatment of severe MRSA infections: current practice and further development. Intensive Care Medicine, 43(2), 233–236. https://doi.org/10.1007/s00134-016-4572-4
Sivagnanam, S., & Deleu, D. (2003). Red man syndrome. Critical Care, 7(2), 119–120. https://doi.org/10.1186/cc1871
Sorensen, S. J., Wise, S. L., Al-Tawfiq, J. A., Robb, J. L., & Cushing, H. E. (1998). Successful vancomycin desensitization in a patient with end-stage renal disease and anaphylactic shock to vancomycin. Annals of Pharmacotherapy, 32(10), 1020–1023. https://doi.org/10.1345/aph.17411
Wazny, L. D., & Daghigh, B. (2001). Desensitization protocols for vancomycin hypersensitivity. Annals of Pharmacotherapy, 35(11), 1458–1464. https://doi.org/10.1345/aph.1A002
Wong, J. T., Ripple, R. E., MacLean, J. A., Marks, D. R., & Bloch, K. J. (1994). Vancomycin hypersensitivity: Synergism with narcotics and. Journal of Allergy and Clinical Immunology, 94(2), 189–194. https://doi.org/10.1053/ai.1994.v94.a55251
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
.